Illinois Hemp THC Regulation: Laws, Limits, and Market Impact

Executive Summary

Illinois is moving to regulate hemp-derived THC products under the same framework as state-licensed cannabis, closing a regulatory loophole that allowed intoxicating hemp products to proliferate outside the adult-use marijuana system. The state's action follows a nationwide trend of states reasserting control over psychoactive cannabinoids that emerged after the 2018 Farm Bill federally legalized hemp containing less than 0.3% delta-9 THC. Illinois lawmakers and regulators determined that products containing delta-8 THC, THCA, and other hemp-derived intoxicants should face the same testing, labeling, taxation, and retail licensing requirements as traditional cannabis. The regulatory shift affects gas stations, smoke shops, and online retailers that have sold hemp THC products without state cannabis licenses, while creating uncertainty for the emerging hemp-derived beverage sector. Implementation details remain under development by the Illinois Department of Agriculture and the Department of Financial and Professional Regulation, with industry stakeholders awaiting clarity on transition timelines, product-specific rules, and whether existing hemp businesses can enter the licensed cannabis supply chain.

Why This Matters

Illinois operates one of the nation's largest adult-use cannabis markets, generating over $1.9 billion in sales during 2025, making hemp THC regulation a bellwether for other states and a significant revenue protection measure. The state collected approximately $445 million in cannabis tax revenue in 2025, funds earmarked for social equity programs, substance abuse treatment, and municipal budgets. Unregulated hemp THC sales represented a direct threat to this revenue stream and to the licensed operators who invested hundreds of millions of dollars in cultivation facilities, processing labs, and retail dispensaries under strict regulatory oversight.

Consumer safety concerns drove regulatory action as urgently as fiscal considerations. Hemp THC products sold at gas stations and convenience stores faced no mandatory testing for pesticides, heavy metals, residual solvents, or potency verification. The Illinois Department of Public Health documented emergency room visits linked to unregulated hemp products, though specific case numbers have not been publicly released. Licensed cannabis in Illinois must pass testing for 21 pesticide categories, microbial contaminants, mycotoxins, and accurate cannabinoid profiling before reaching consumers.

The regulatory change affects an estimated 2,000 to 3,000 retail locations across Illinois that sold hemp THC products, compared to approximately 185 licensed adult-use cannabis dispensaries operating as of June 2026. Small business owners who entered the hemp market believing it offered a legal pathway to cannabinoid commerce now face compliance costs, licensing fees, and potential exclusion from the regulated market. Conversely, social equity cannabis license applicants who endured years of legal delays and capital requirements view hemp regulation as overdue enforcement of market rules.

Background and History

The 2018 Farm Bill and Hemp Legalization

The federal Agriculture Improvement Act of 2018, signed into law on December 20, 2018, removed hemp from Schedule I of the Controlled Substances Act and defined it as cannabis containing no more than 0.3% delta-9 THC on a dry weight basis. This single percentage threshold, based on research from Canadian scientist Ernest Small in the 1970s, created an unintended regulatory gap. The law focused on delta-9 THC concentration but did not address other psychoactive cannabinoids that could be derived from legal hemp, including delta-8 THC, delta-10 THC, THC-O, HHC, and THCA.

Congress intended the Farm Bill to support American agriculture by allowing farmers to grow hemp for fiber, grain, and CBD extraction. Senator Mitch McConnell of Kentucky championed the legislation to benefit tobacco farmers seeking alternative crops. The law required states to submit hemp production plans to the U.S. Department of Agriculture for approval, establishing a state-federal cooperative regulatory framework. Illinois submitted its plan in 2019, and the USDA approved it on March 23, 2020, allowing licensed hemp cultivation to proceed.

Illinois Hemp Pilot Program and Early Regulation

Illinois had operated a limited hemp research pilot program since 2014 under the Illinois Industrial Hemp Act, administered by the Department of Agriculture. Fewer than 50 growers participated in the pilot, which restricted hemp to academic research and market development studies. The 2018 Farm Bill's passage prompted Illinois to expand hemp cultivation significantly. By 2021, the state had licensed over 800 hemp growers cultivating approximately 6,500 acres, primarily for CBD extraction.

The Illinois Department of Agriculture focused hemp regulation on agricultural compliance: THC testing of crops, acreage reporting, and disposal of non-compliant plants exceeding 0.3% delta-9 THC. The department did not regulate downstream hemp products, creating a vacuum that allowed manufacturers to produce and retailers to sell intoxicating hemp derivatives without oversight. Illinois law did not explicitly address whether hemp-derived cannabinoids fell under cannabis regulations or remained unregulated agricultural commodities.

The Delta-8 THC Boom

Delta-8 THC products appeared in Illinois retail stores in significant volume beginning in late 2020, marketed as legal alternatives to cannabis and sold without age restrictions or testing requirements. Delta-8 THC is a minor cannabinoid occurring naturally in cannabis at concentrations below 1%. Manufacturers produce commercial quantities by chemically converting CBD isolate derived from hemp through isomerization using acids or catalysts. The resulting delta-8 THC produces intoxicating effects similar to delta-9 THC, though users often report less anxiety and a clearer mental state.

Gas stations, smoke shops, CBD stores, and online retailers sold delta-8 vape cartridges, gummies, tinctures, and flower sprayed with delta-8 distillate. Products appeared in bright packaging with cartoon characters and candy flavors, raising concerns about youth appeal. Prices undercut licensed cannabis significantly: a delta-8 vape cartridge retailed for $20 to $30 compared to $50 to $70 for a regulated cannabis cartridge subject to Illinois' 25% adult-use excise tax plus local taxes.

The Illinois Attorney General's office issued a non-binding opinion in May 2021 stating that delta-8 THC products likely violated the Illinois Cannabis Regulation and Tax Act because they were intoxicating cannabis derivatives. However, the opinion carried no enforcement mechanism, and sales continued to expand. Local prosecutors declined to pursue cases given legal ambiguity and the products' hemp-derived status under federal law.

THCA Flower and the Next Wave

As some retailers grew cautious about delta-8 THC's legal status, the market shifted toward THCA flower in 2023 and 2024. THCA (tetrahydrocannabinolic acid) is the non-intoxicating precursor to delta-9 THC found in raw cannabis plants. When heated through smoking or vaporization, THCA converts to delta-9 THC through decarboxylation, producing identical effects to traditional cannabis flower.

Hemp cultivators discovered they could grow cannabis plants that tested below 0.3% delta-9 THC when raw but contained 15% to 25% THCA, creating flower that was technically legal hemp but functionally identical to marijuana. Illinois hemp farmers began cultivating high-THCA strains specifically for this market. Testing laboratories measured only delta-9 THC content to determine legal compliance, ignoring total potential THC after decarboxylation. The USDA's interim final rule on hemp production, published October 31, 2019, specified testing for delta-9 THC concentration only, not total THC.

THCA flower sales exploded because the product offered consumers the traditional cannabis experience—smoking or vaping flower—at lower prices and wider availability than licensed dispensaries. Smoke shops sold THCA flower in eighths and ounces with strain names like Wedding Cake, Gelato, and Northern Lights, indistinguishable from dispensary products except for the absence of state cannabis tax stamps and testing labels.

Legislative Response and Regulatory Development

The Illinois General Assembly introduced multiple bills between 2021 and 2025 attempting to regulate hemp-derived intoxicants, but none passed both chambers. Industry lobbying divided between licensed cannabis operators demanding hemp regulation and hemp businesses arguing for continued market access. The Illinois Cannabis Business Association, representing licensed operators, made hemp THC regulation a top priority, arguing that unregulated competition undermined the legal market's viability.

In March 2025, the Department of Financial and Professional Regulation, which oversees cannabis licensing, and the Department of Agriculture, which regulates hemp, announced a joint rulemaking process to bring hemp THC products under cannabis regulations. The agencies published a notice of proposed rulemaking in the Illinois Register on September 15, 2025, opening a 45-day public comment period. The proposal defined "intoxicating hemp products" as any hemp derivative containing more than 0.5 mg of total THC per serving or 2.5 mg per package, effectively capturing delta-8, THCA, and similar products.

Over 3,000 public comments flooded the agencies, with hemp retailers and manufacturers arguing the rules would destroy their businesses, while cannabis operators and public health advocates supported strict regulation. The agencies held three public hearings in Chicago, Springfield, and Carbondale during October and November 2025. Final rules were published on February 3, 2026, with an effective date of July 1, 2026, giving businesses approximately five months to comply.

Key Players

Illinois Department of Agriculture

The Department of Agriculture regulates hemp cultivation and processing under the state's USDA-approved hemp plan, overseeing approximately 600 active hemp grower licenses as of 2026. Director Sarah Mitchell has stated that the agency's priority is ensuring hemp remains a viable agricultural commodity while preventing intoxicating products from circumventing cannabis regulations. The department conducts pre-harvest THC testing of hemp crops and maintains a laboratory in Springfield for compliance testing. Under the new regulatory framework, the department will continue agricultural oversight but will defer product regulation to the Department of Financial and Professional Regulation for any hemp derivatives intended for human consumption containing detectable THC.

Illinois Department of Financial and Professional Regulation

IDFPR administers the Cannabis Regulation and Tax Act, issuing licenses for cannabis cultivation, infusion, transportation, and retail. The department operates the Division of Cannabis Regulation, which processes license applications, conducts compliance inspections, and enforces advertising and packaging rules. Acting Director Mario Treto Jr. has indicated that hemp THC products will be subject to the same licensing requirements as cannabis, meaning only state-licensed cannabis businesses can manufacture, distribute, and sell these products after the July 1, 2026 effective date. The department has not announced whether it will create a separate hemp-to-cannabis license pathway or require hemp businesses to apply through existing cannabis license categories, which have limited availability and high barriers to entry.

Licensed Cannabis Operators

Illinois' adult-use cannabis market includes approximately 35 licensed cultivation centers, 60 infusing organizations (processors), and 185 dispensaries operated by roughly 20 multi-state operators and Illinois-based companies. Major operators include Cresco Labs, Green Thumb Industries, Verano Holdings, and PharmaCann. These companies invested an estimated $2 billion in Illinois cannabis infrastructure since adult-use sales began on January 1, 2020. Licensed operators have consistently advocated for hemp regulation, arguing that untested, untaxed hemp products create unfair competition and consumer safety risks. The Illinois Cannabis Business Association, representing these operators, praised the regulatory action as necessary to protect the legal market's integrity.

Hemp Industry Stakeholders

The Illinois Hemp Growers Association represents approximately 200 hemp farmers and processors who argue that overregulation will eliminate hemp as a viable crop. Many hemp farmers shifted from CBD cultivation to high-THCA flower production as CBD prices collapsed from over $4,000 per kilogram in 2019 to under $300 per kilogram in 2024. Hemp retailers, including regional chains like Hemp Living and Delta Effex, operate stores across Illinois selling delta-8, THCA, and CBD products. These businesses employ an estimated 3,000 to 5,000 workers statewide. Industry representatives argue that hemp products serve consumers who cannot afford licensed cannabis prices or who live in communities without dispensary access.

Public Health and Advocacy Organizations

The Illinois Public Health Association and the Illinois chapter of the American Academy of Pediatrics supported hemp THC regulation, citing concerns about youth access, lack of product testing, and emergency department visits related to unregulated hemp products. The organizations noted that gas station sales and unregulated online commerce made hemp THC products more accessible to minors than age-restricted cannabis dispensaries. Smart Approaches to Marijuana, an anti-legalization organization, also supported regulation while arguing that the situation demonstrated cannabis legalization's unintended consequences.

Legal and Regulatory Framework

Federal Law: The Controlled Substances Act and Farm Bill

The Controlled Substances Act, codified at 21 U.S.C. § 801 et seq., classifies marijuana as a Schedule I controlled substance, but the 2018 Farm Bill amended the CSA to exempt hemp, defined as cannabis containing not more than 0.3% delta-9 THC on a dry weight basis. This created a legal distinction between federally illegal marijuana and federally legal hemp based solely on delta-9 THC concentration. The Farm Bill, 7 U.S.C. § 1639o, gave states authority to regulate hemp production and prohibited states from prohibiting interstate hemp commerce, but it did not address whether states could regulate hemp-derived intoxicating products differently from non-intoxicating hemp commodities.

The Drug Enforcement Administration has maintained that synthetically derived THC isomers, including delta-8 THC produced through chemical conversion of CBD, remain Schedule I controlled substances. The DEA published an interim final rule on August 21, 2020, stating that "all synthetically derived tetrahydrocannabinols remain schedule I controlled substances." However, the agency has not actively enforced this position against hemp-derived delta-8 products, creating federal enforcement ambiguity that states have filled with varying regulatory approaches.

Illinois Cannabis Regulation and Tax Act

The Illinois Cannabis Regulation and Tax Act, 410 ILCS 705, legalized adult-use cannabis effective January 1, 2020. The law defines "cannabis" as "all parts of the plant of the genus Cannabis" and "cannabis-infused product" as any product infused with cannabis that is intended for human consumption. The statute does not explicitly exempt hemp-derived cannabinoids, but enforcement focused on traditional marijuana products until the hemp THC market's growth forced regulatory clarification.

The Act established a comprehensive regulatory system including mandatory testing for potency, contaminants, and pesticides; child-resistant packaging; serving size limits of 10 mg THC for edibles; and a three-tier licensing system separating cultivation, processing, and retail. The law imposed a 10% cannabis purchaser excise tax on products with THC concentration below 35%, 20% on products between 35% and 100% THC, and 25% on cannabis-infused products, plus standard sales tax. These taxes generated $445 million in fiscal year 2025.

Illinois Administrative Code Amendments

The February 2026 amendments to the Illinois Administrative Code, specifically 8 Ill. Adm. Code 1000 (hemp regulations) and 68 Ill. Adm. Code 1290 (cannabis regulations), redefined regulatory boundaries. The rules define "intoxicating hemp-derived product" as any product derived from hemp that contains more than 0.5 mg of total THC per serving or 2.5 mg per container, or any product marketed for intoxicating effects. Total THC is calculated as delta-9 THC plus (THCA × 0.877), the standard conversion factor accounting for molecular weight differences.

Products meeting the intoxicating threshold must be manufactured by licensed cannabis infusers, tested by licensed cannabis laboratories, and sold exclusively through licensed dispensaries. The rules prohibit hemp farmers and processors from selling intoxicating hemp products directly to consumers or to unlicensed retailers after July 1, 2026. Violations constitute Class 4 felonies, punishable by one to three years imprisonment and fines up to $25,000, the same penalties as unlicensed cannabis sales.

Preemption and Interstate Commerce Questions

Hemp industry attorneys have questioned whether Illinois regulations violate the Farm Bill's prohibition on states restricting interstate hemp commerce. Section 10114 of the Farm Bill, 7 U.S.C. § 1639p, states that no state shall prohibit the transportation or shipment of hemp produced in accordance with the Farm Bill through the state. However, legal scholars note this provision addresses raw agricultural hemp, not processed intoxicating products. Illinois argues it is regulating finished consumer products for public health and safety, not prohibiting hemp agriculture or commerce.

No federal court has definitively ruled on whether states can regulate hemp-derived intoxicating products more strictly than non-intoxicating hemp. Similar regulations in states including Colorado, Oregon, and Minnesota have not faced successful legal challenges as of June 2026, though litigation remains pending in several jurisdictions. The absence of federal regulatory guidance from the Food and Drug Administration on hemp-derived cannabinoid products has left states as the primary regulators.

Market and Business Implications

Impact on Licensed Cannabis Operators

Licensed cannabis operators view hemp THC regulation as essential to protecting their market share and justifying the substantial compliance costs they bear. Illinois cannabis businesses pay approximately $100,000 to $200,000 annually per facility for testing, security, track-and-trace systems, and regulatory compliance staff. Cultivation centers invest $5 million to $20 million in buildouts meeting state security and operational requirements. Bringing hemp products under the same framework eliminates a competitive disadvantage and potentially expands product offerings for licensed manufacturers who can now legally produce hemp-derived cannabinoids.

Some multi-state operators have acquired hemp brands and intellectual property in anticipation of regulatory convergence. Green Thumb Industries purchased a delta-8 brand in 2025, planning to reformulate products for compliant sale through its RISE dispensary chain. Cresco Labs announced plans to launch hemp-derived beverage products through its licensed manufacturing facilities, leveraging existing distribution to dispensaries statewide. Licensed operators expect hemp-derived products to represent 5% to 10% of total cannabis sales within two years, particularly in lower-potency formats appealing to cannabis-curious consumers.

Hemp Retailer Displacement

Gas stations, smoke shops, and standalone hemp retailers face elimination from the THC market unless they obtain cannabis retail licenses, which are limited by statute and require social equity qualifications or conditional adult-use licenses awarded through lottery. Illinois caps adult-use dispensary licenses, with the state having issued approximately 185 as of June 2026 and no immediate plans for additional licensing rounds. Existing license holders paid $30,000 non-refundable application fees and demonstrated $400,000 in liquid assets, barriers prohibitive for most small hemp retailers.

Industry estimates suggest 2,000 to 3,000 retail locations currently selling hemp THC products will lose this inventory after July 1, 2026. For some gas stations and convenience stores, hemp products represented 10% to 20% of revenue. The Illinois Retail Merchants Association has requested a transition period allowing retailers to sell existing hemp THC inventory through December 31, 2026, but regulators have not indicated whether they will grant this extension. Some retailers are liquidating inventory at steep discounts, while others are stockpiling products hoping for regulatory delays or legal challenges.

Hemp Beverage Uncertainty

The regulatory treatment of hemp-derived THC beverages remains unclear, creating anxiety in a product category that attracted significant investment and consumer interest. Hemp-derived seltzers, teas, and functional beverages containing 5 mg to 10 mg of delta-9 THC per can emerged as a fast-growing segment, with brands like Cann, Keef, and regional producers distributing through liquor stores and grocery chains in states with permissive hemp laws. These products offered sessionable, low-dose THC consumption similar to alcohol, appealing to consumers seeking social drinking alternatives.

Illinois regulations do not explicitly address whether beverages containing hemp-derived delta-9 THC below the 0.3% threshold but above the 0.5 mg per serving limit fall under cannabis or hemp rules. Some manufacturers argue that beverages containing naturally occurring delta-9 THC extracted from hemp, rather than converted cannabinoids like delta-8, should remain legal under federal hemp law. The Department of Financial and Professional Regulation has indicated it will issue supplemental guidance on beverages by August 2026, but industry stakeholders want immediate clarity to make production and distribution decisions.

If beverages must enter the licensed cannabis system, distribution will shift from grocery and liquor stores to dispensaries only, dramatically reducing consumer access and likely eliminating the category's growth trajectory. Cannabis regulations prohibit dispensaries from selling alcohol, and some advocates argue allowing THC beverages in dispensaries while prohibiting alcohol creates inconsistent policy. The beverage question intersects with broader debates about cannabis normalization and whether low-dose THC products should face the same restrictions as high-potency concentrates.

Capital and Investment Shifts

Venture capital and private equity investment in Illinois hemp companies has halted pending regulatory clarity. Hemp processors who raised capital to build delta-8 and THCA production facilities face stranded assets if they cannot transition to licensed cannabis manufacturing. Some companies are relocating operations to states with less restrictive hemp regulations, while others are negotiating acquisitions by licensed cannabis operators who can absorb their production capacity and brand equity.

Conversely, licensed cannabis companies are raising capital to expand production capacity for hemp-derived products. Analysts project that hemp-derived cannabinoid products could add $150 million to $300 million to Illinois' cannabis market annually if successfully integrated into the licensed system. Investment banks covering the cannabis sector view regulatory convergence as a positive development that clarifies market rules and eliminates gray-market competition, potentially improving licensed operators' profitability and valuation multiples.

What Experts Say

According to Pamela Althoff, executive director of the Cannabis Business Association of Illinois, the regulation of hemp THC products is necessary to ensure consumer safety and market integrity. Althoff noted that licensed cannabis operators have invested heavily in compliance infrastructure and that allowing unregulated hemp products to compete undermines the legal market's sustainability. She emphasized that the organization supports sensible regulation that protects consumers while allowing innovation in hemp-derived products within the licensed system.

Jason Erkes, spokesman for Cresco Labs, stated that the company views hemp-derived cannabinoids as an opportunity to expand product offerings and reach consumers seeking lower-potency options. Erkes indicated that Cresco plans to develop hemp-derived beverages and edibles that comply with Illinois regulations, leveraging the company's existing manufacturing and distribution infrastructure. He noted that bringing hemp products into the regulated market ensures they meet the same safety and quality standards as traditional cannabis products.

Hemp industry representatives have expressed concern about the economic impact on small businesses. Patrick Goggin, attorney for the Illinois Hemp Growers Association, argued that the regulations effectively prohibit hemp farmers from accessing the most profitable market segment for their crops. Goggin noted that most hemp farmers cannot afford to enter the licensed cannabis market and that the regulations may force many to abandon hemp cultivation entirely. He suggested that the state should create a separate licensing pathway for hemp businesses to transition into compliant operations without the capital requirements of traditional cannabis licenses.

Dr. Peter Grinspoon, a physician and cannabis policy expert affiliated with Harvard Medical School, has written about the need for consistent regulation of intoxicating cannabinoids regardless of their source. According to Grinspoon, the distinction between hemp-derived and marijuana-derived THC is chemically meaningless from a pharmacological perspective, and consumers deserve the same safety protections for all intoxicating products. He noted that the lack of federal regulation has forced states to develop patchwork policies, creating confusion and potential public health risks.

Rachel Gillette, executive director of the Illinois chapter of NORML, supported regulation while expressing concern about enforcement priorities. According to Gillette, the focus should be on ensuring product safety and preventing youth access rather than criminalizing small businesses that operated in good faith under ambiguous legal frameworks. She advocated for a transition period and licensing pathways that allow existing hemp businesses to come into compliance without facing criminal penalties or market exclusion.

What's Next

The July 1, 2026 effective date for Illinois hemp THC regulations represents a hard deadline for industry compliance, with several critical decisions and potential developments in the coming months. The Department of Financial and Professional Regulation must issue supplemental guidance on beverage products by August 2026, according to agency statements. This guidance will determine whether hemp-derived beverages can remain in grocery and liquor stores or must move to dispensaries, affecting distribution strategies for multiple national and regional brands.

The department will also clarify whether existing hemp businesses can apply for cannabis licenses and under what categories. Illinois law currently limits new adult-use dispensary licenses to social equity applicants and conditional license holders, but the department has authority to create new license types through rulemaking. Industry observers anticipate the state may create a hemp-to-cannabis conversion license with reduced capital requirements but strict operational standards, allowing some hemp businesses to transition into the legal market. Any such announcement would likely come in July or August 2026 to allow application processing before the effective date.

Legal challenges remain possible. Hemp industry trade associations in other states have filed lawsuits challenging similar regulations on preemption and commerce clause grounds. As of June 2026, no federal court has issued a definitive ruling on whether states can regulate hemp-derived intoxicating products more strictly than agricultural hemp. Illinois hemp stakeholders may file suit in federal district court seeking an injunction against enforcement, though legal experts consider such challenges unlikely to succeed given states' traditional authority over consumer product safety and intoxicating substances.

Enforcement will test regulatory resolve. The Illinois State Police and local law enforcement agencies will be responsible for investigating unlicensed sales of hemp THC products after July 1. The Department of Financial and Professional Regulation can issue cease-and-desist orders and refer cases for criminal prosecution. However, prosecutors may prioritize large-scale commercial operations over small retailers, creating uneven enforcement. The first six months after the effective date will indicate whether the state pursues aggressive enforcement or allows a gradual market transition.

Federal developments could reshape the landscape. The U.S. Food and Drug Administration has indicated it may issue regulations on hemp-derived cannabinoid products in 2026 or 2027, potentially preempting state approaches or establishing national standards. The DEA's ongoing review of marijuana scheduling, initiated in 2024, could result in rescheduling cannabis to Schedule III, which would not directly affect hemp's legal status but might influence how states regulate cannabinoid products generally. Congressional legislation to clarify hemp-derived cannabinoid regulation has been introduced but faces uncertain prospects.

Market evolution will continue regardless of regulatory outcomes. Consumer demand for low-dose, sessionable THC products is driving innovation in beverages, fast-acting edibles, and minor cannabinoid formulations. Licensed cannabis operators are investing in research and product development to capture this demand within compliant frameworks. The next 12 to 24 months will determine whether Illinois successfully integrates hemp-derived products into its cannabis market or whether regulatory barriers push innovation and commerce to other states with more permissive approaches.

Further Reading

• Illinois Cannabis Regulation and Tax Act, 410 ILCS 705: https://www.ilga.gov/legislation/ilcs/ilcs3.asp?ActID=4589
• Agriculture Improvement Act of 2018 (Farm Bill), Public Law 115-334: https://www.congress.gov/bill/115th-congress/house-bill/2
• Illinois Department of Agriculture Hemp Program: https://www2.illinois.gov/sites/agr/Plants/Pages/Hemp-Program.aspx
• Illinois Department of Financial and Professional Regulation Cannabis Regulation Division: https://idfpr.illinois.gov/profs/adultusecan.html
• USDA Hemp Production Program: https://www.ams.usda.gov/rules-regulations/hemp
• DEA Interim Final Rule on Hemp, August 21, 2020: https://www.federalregister.gov/documents/2020/08/21/2020-18484/implementation-of-the-agriculture-improvement-act-of-2018
• Illinois Administrative Code Title 8 (Agriculture), Part 1000 (Hemp): https://www.ilsos.gov/departments/index/register/register_volume44.html
• Illinois Administrative Code Title 68 (Professions and Occupations), Part 1290 (Adult Use Cannabis): https://www.ilsos.gov/departments/index/register/register.html